Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyciphage P 7.5 mg/500 mg Tablet

Prescription Icon
Prescription Required

Marketer

Franco-Indian Pharmaceuticals Pvt Ltd

Salt Composition

Pioglitazone (7.5mg) + Metformin (500mg)

Overview Glyciphage P 7.5 mg/500 mg Tablet

Metformin and Gliclazide 7.5mg/500mg tablets are a dual-action medication designed to manage elevated blood glucose. This combination therapy, used alongside a healthy diet and regular exercise, improves glycemic control in adult patients with type 2 diabetes. It enhances insulin effectiveness, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for Metformin and Gliclazide 7.5mg/500mg tablets. Taking this medication with food minimizes potential stomach discomfort. If a dose is missed, take it immediately; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. An overdose can result in hypoglycemia (low blood sugar). Minor side effects, such as nausea, appetite suppression, altered taste perception, abdominal pain, diarrhea, and edema, may occur but are generally mild. Persistent or concerning side effects warrant medical attention. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Expectant or lactating mothers must consult their physician before use. Kidney function will be assessed by your doctor before initiating therapy. Limit alcohol consumption during treatment to mitigate potential side effects.

Uses of Glyciphage P 7.5 mg/500 mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glyciphage P 7.5 mg/500 mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glyciphage P 7.5 mg/500 mg tablet should be administered with a meal.

Common Side effects of Glyciphage P 7.5 mg/500 mg Tablet:

  • Diarrhea
  • Edema (swelling)
  • Headache
  • Nausea
  • Vomiting
  • Hypoglycemia (low blood glucose level)
  • Dizziness
  • Urinary tract infection
  • Upper respiratory tract infection
  • Sinus infection

How to use Glyciphage P 7.5 mg/500 mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glyciphage P 7.5 mg/500 mg tablets should be administered with a meal.

How Glyciphage P 7.5 mg/500 mg Tablet works:

Metformin and glimepiride, in a 500mg/7.5mg tablet formulation (Glyciphage P), offer a dual-action approach to diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Glyciphage P 7.5 mg/500 mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glyciphage P 7.5 mg/500 mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glyciphage P 7.5 mg/500 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glyciphage P 7.5 mg/500 mg tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated for individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glyciphage P 7.5 mg/500 mg tablets cautiously. Dosage modifications may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Glyciphage P 7.5 mg/500 mg tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glyciphage P 7.5 mg/500 mg Tablet :

Should you forget a Glyciphage P 7.5 mg/500 mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyciphage P 7.5 mg/500 mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Glyciphage P 7.5 mg/500 m...
44
MRP 54
18% off